Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision tag was introduced: Revision: v3.5.4, replacing Revision: v3.5.3. This signals a minor update to the page release and does not modify the study content or data shown on the record.
    Difference
    0.0%
    Check dated 2026-05-15T05:10:45.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, indicating a new release/version. This update does not modify the study data or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T18:01:54.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-16T11:50:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added site revision: Revision: v3.5.0. Deleted site revision: Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:48:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:36:41.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Administrative update: Revision v3.4.2 was added and the previous operating-status notice (rev. 3.4.1) was removed; there is no change to the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:46:09.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.